New selective PAD4 inhibitors binding a calcium-deficient type of the PAD4 enzyme have validated the crucial enzymatic function of human and mouse PAD4 in each histone citrullination and neutrophil extracellular entice formation for, to our know-how, the first time. The therapeutic prospective of PAD4 inhibitors can now be explored. This https://philw110jvg3.get-blogging.com/profile